ResMed Inc
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Americas Devices Revenue: $436M in Q1 FY27, up 5.6% from a year earlier.
Latest, Q1 FY27
436
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
+5.6%
413 in Q1 FY26
History
25 quarters
Since Q1 FY21
Sources
20
Documents cited below
Where the Q1 FY27 figure comes from
Source: ResMed SEC Filing (0000943819-26-000089) ↗
Reported in ResMed Form 10-K/10-Q Segment Disclosures & Form 8-K Revenue by Product and Region Tables.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up americas Devices Revenue
Cite this data
StockData. (2026). ResMed Americas Devices Revenue ($M), quarterly Q1 FY21–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-amer-rev
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?